You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 9, March 5, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Papanicolaou Smear

Medicine's Most Successful Cancer Screening Procedure Is Threatened

R. Marshall Austin, MD, PhD; William W. McLendon, MD

JAMA. 1997;277(9):754-755.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the first definitive medical journal publication of early results from the use of the cervicovaginal smear of exfoliated cells for the detection of carcinoma of the cervix and uterus, Papanicolaou and Traut1 stated in 1941 that there were some 26 000 deaths a year in the United States due to cancer of the uterus and that "this rate has remained practically constant during the past twenty-five years."1 In 1996, deaths from cervical cancer in the United States are estimated to be 4900 per year.2 Considering the almost 2-fold increase in population during the intervening half century, this is truly a remarkable accomplishment.

See also the March 1997 issue of Archives of Pathology & Laboratory Medicine.

Much of this progress during the past half century in converting cervical cancer from the No. 1 cancer killer of women in the United States to the No. 8 killer2 . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Pathology and Laboratory Medicine and of Obstetrics and Gynecology, Roper Hospital and The Medical University of South Carolina, Charleston (Dr Austin), and the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (Dr McLendon). Dr McLendon is Editor of Archives of Pathology & Laboratory Medicine.


Footnotes

Reprints: William W. McLendon, MD, Department of Pathology and Laboratory Medicine, CB 7525, University of North Carolina, Chapel Hill, NC 27599-7525.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.